Rejected
at 2:02 a.m. Nov, 01, 2023 ]
by
Ahmed7
Author:
vellistar
Type of change:
Updated content
Rationale for change
updated in uworld 2023 version---for the extra section, valbenazine should be listed along with deutatrabenazine as both are approved vmat2 inhibitors by the FDA. it's in uworld and i can send a screenshot if you would like. and the uworld table in the note is also out of date in this card. i put deutetrabenazine in the edit.
Rejection reason
please include QID
Current
Suggested
Extra
Extra
Extra
Extra
Text
What is the next step in management for a patient who requires antipsychotics but develops tardive dyskinesia while taking risperidone?
{{c1::Switch to clozapine or quetiapine}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
.png)

.png)

One by one
Empty field



